Non-interventional Study on the Safety and Efficacy for Prevention and Treatment of Fungal Infections in Paediatric Patients in Asia/Oceania - ERADICATE Study

Trial Profile

Non-interventional Study on the Safety and Efficacy for Prevention and Treatment of Fungal Infections in Paediatric Patients in Asia/Oceania - ERADICATE Study

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Aug 2018

At a glance

  • Drugs Micafungin (Primary)
  • Indications Mycoses
  • Focus Adverse reactions
  • Acronyms ERADICATE
  • Sponsors Astellas Pharma
  • Most Recent Events

    • 24 Jul 2018 Status changed from active, no longer recruiting to completed.
    • 07 Jun 2018 Planned End Date changed from 1 Nov 2019 to 1 Jun 2018.
    • 07 Jun 2018 Planned primary completion date changed from 1 Nov 2019 to 1 Jun 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top